티앤알바이오팹·싸이토젠 코스닥 상장예비심사 통과

글 내용 전체보기

한미, 국제학회서 8건 연구 소개…’랩스커버리 진화’

글 내용 전체보기

HIV Treatments That Could Make Redfield’s Prediction a Reality to Defeat AIDS Epidemic

글 내용 전체보기

Arrowhead Goes All in With J&J to Develop Hep B Drug for $3.7B

글 내용 전체보기

Boehringer and Lilly’s Jardiance Looks Good for Type I Diabetes

글 내용 전체보기

Bayer Cutting More Than 200 Jobs in San Francisco Bay Area

글 내용 전체보기

It’s Flu Season! Genentech’s Investigational Medicine Continues to Show Efficacy

글 내용 전체보기

In Small Patient Group, Sarepta’s DMD Gene Therapy Gives Some Hope

글 내용 전체보기

Why Does Immunotherapy Cost So Much?

글 내용 전체보기

Technology Is Revolutionizing Clinical Trials: Here’s How

글 내용 전체보기

It Seems Counterintuitive, but Inspirational Bosses Can Sometimes Harm Employees’ Health

글 내용 전체보기

Orchard Therapeutics Receives EMA PRIME Designation for OTL-300, an Investigational Lentiviral Gene Therapy for the Treatment of Transfusion-Dependent Beta-Thalassemia

글 내용 전체보기

MetP® Pharma Introduces Nascum®-Plus Against the Onset of Air Pollution-induced Inflammation

글 내용 전체보기

Want a glimpse into pharma’s future? Look to cable television, Merck CEO says

글 내용 전체보기

Disgruntled Takeda alumni demand a window into $62B Shire buy

글 내용 전체보기

BIO’s ultimatum to members: Get serious about gender diversity or face our fury

글 내용 전체보기

One way to thwart generics delays? Look skeptically at citizen petitions, FDA says

글 내용 전체보기

As Jivi launches, Bayer cuts 227 workers at U.S. plant that produces hemophilia treatment

글 내용 전체보기

EuroBiotech Report—Roche inks cancer deals, Forbion’s €360M fund, U.K. VC soars and Gamida

글 내용 전체보기

EuroBiotech: More Articles of Note

글 내용 전체보기

Nimbus moves up CFO Keiper to CEO spot

글 내용 전체보기